Archives of Cardiovascular Diseases

Papers
(The H4-Index of Archives of Cardiovascular Diseases is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Drug-induced spontaneous coronary artery dissection: Analysis of the WHO pharmacovigilance database43
Development of an orthoptic aortic valve replacement model in Yucatan minipig to study the degeneration of bioprosthetic valve32
Investigating risk of cancer with SGLT-2 Inhibitors: A Case/Non-Case Study in the WHO Global Pharmacovigilance Database Vigibase25
Usefulness of ECG smart watches for detection of symptomatic intermittent arrythmias: Comparison with 24 h Holter ECG24
Editorial board23
Acknowledging our reviewers23
One-year aortic diameter remodeling after the simplified delivery frozen elephant trunk technique in acute aortic dissection23
Screening for arteriopathy obliterants of the lower limbs by measurement of the systolic pressure index in patients living with hiv on antiretrovirals at the fann regional research and training center22
Identification of new phenotypes in type 2 diabetes with acute myocardial infarction: Toward a precision medicine?22
Cardiogenic shock: Management and prognosis depending on use of inotropic and vasopressor agents20
Demographic and regional disparities in adult thoracic aortic aneurysm-related mortality rates in the USA: Insights from a CDC WONDER analysis (1999–2020)19
Response to a letter from Tomoyuki Kawada commenting on the article entitled “Sex-specific predictive factors of smoking cessation in subjects at high cardiovascular risk”18
Transcriptomic profile helps to identify high-risk heterozygous familial hypercholesterolemia patients18
Feasibility and accuracy of virtual reality for surgical and interventional planning for sinus venosus atrial septal defect repair18
Distinct Ca2+ handling modulation in a rat model of right hypertrophy and dysfunction in response to mild or severe pulmonary artery constriction17
In female weight cycling mice, administration of the mineralocorticoid receptor antagonist finerenone during a phase of calorie restriction prevents the development of HFpEF16
0.73395609855652